BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15146680)

  • 1. [Drug industry and bribes].
    Annertz M
    Lakartidningen; 2004 Apr; 101(15-16):1436. PubMed ID: 15146680
    [No Abstract]   [Full Text] [Related]  

  • 2. Future directions in industry funding of continuing medical education.
    Steinbrook R
    Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
    [No Abstract]   [Full Text] [Related]  

  • 3. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription for conflict. AMA accepts funding from drug firms for campaign.
    Romano M
    Mod Healthc; 2001 Jun; 31(25):14. PubMed ID: 11436381
    [No Abstract]   [Full Text] [Related]  

  • 5. Must "no see" always mean a "no know"?
    Gamble GL
    PM R; 2009 Jan; 1(1):87-8. PubMed ID: 19627879
    [No Abstract]   [Full Text] [Related]  

  • 6. When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure.
    Hensley S
    Wall St J (East Ed); 2002 Dec; ():A1, A12. PubMed ID: 12653117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug indoctrination or education? You are member of the county council's political committee].
    Andrén-Sandberg A
    Lakartidningen; 2003 Oct; 100(42):3328-32. PubMed ID: 14619046
    [No Abstract]   [Full Text] [Related]  

  • 8. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Commercialization of the medical research is a reality. What is the limit?].
    Naeser K
    Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry sponsorship of scientific meetings: peaks and troughs.
    Isaacs D
    J Paediatr Child Health; 2012 Jul; 48(7):547. PubMed ID: 22758896
    [No Abstract]   [Full Text] [Related]  

  • 11. Does industry have a role in medical education?
    Pellman H
    Arch Intern Med; 2011 Aug; 171(15):1404. PubMed ID: 21824965
    [No Abstract]   [Full Text] [Related]  

  • 12. Is academic medicine for sale?
    Norton JW
    N Engl J Med; 2000 Aug; 343(7):508; author reply 510. PubMed ID: 10950669
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug company marketing in the groves of academe.
    Schwartz TB
    West J Med; 1992 Jun; 156(6):660-1. PubMed ID: 1615668
    [No Abstract]   [Full Text] [Related]  

  • 14. Individual wariness needed to spot biased drug research.
    Lazarus A
    Manag Care; 2005 Sep; 14(9):8, 13. PubMed ID: 16238253
    [No Abstract]   [Full Text] [Related]  

  • 15. [When will we see "Physicians without sponsors" in Sweden?].
    Lindberg M
    Lakartidningen; 2005 Jun 6-12; 102(23):1830. PubMed ID: 15997555
    [No Abstract]   [Full Text] [Related]  

  • 16. Successes, challenges emerge from efforts to shift away from industry-funded CME.
    Kuehn BM
    JAMA; 2010 Aug; 304(7):729-31. PubMed ID: 20716730
    [No Abstract]   [Full Text] [Related]  

  • 17. Financial support of continuing medical education.
    Steinbrook R
    JAMA; 2008 Mar; 299(9):1060-2. PubMed ID: 18319417
    [No Abstract]   [Full Text] [Related]  

  • 18. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
    Romano M
    Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773
    [No Abstract]   [Full Text] [Related]  

  • 19. [The medical-industrial complex: an ethical challenge].
    Engelhardt K
    Dtsch Med Wochenschr; 2005 Jul; 130(30):1778-80. PubMed ID: 16049885
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmaceutical industry and continuing education.
    Madlon-Kay DJ
    JAMA; 2001 Jul; 286(3):303-4. PubMed ID: 11466089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.